Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership8,110,116 shares
Latest Disclosed Value $ 1,238,669,129
Dimensional Fund Advisors Lp reports 4.86% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 8,110,116 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $1,238,820,219 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 8,524,394 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -4.86% during the quarter. The current value of the position is $1,209,704,903 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,110,116 -414,278 -4.86 1,238,669 5.39 0.0555
2026-02-12 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,524,394 -316,292 -3.58 1,175,312 3.69 0.2465
2025-11-12 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,840,686 -220,209 -2.43 1,133,468 3.38 0.2432
2025-08-12 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,060,895 454,171 5.28 1,096,396 14.26 0.2538
2025-05-13 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,606,724 422,869 5.17 959,535 20.49 0.2385
2025-02-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,183,855 90,823 1.12 796,372 -14.45 0.1913
2024-11-07 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,093,032 685,340 9.25 930,892 18.04 0.2258
2024-08-09 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,407,692 1,389,610 23.09 788,626 35.47 0.2060
2024-05-10 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,018,082 -60,093 -0.99 582,129 -5.14 0.1576
2024-02-07 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,078,175 -195,711 -3.12 613,700 -3.97 0.1792
2023-11-09 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,273,886 16,543 0.26 639,064 1.21 0.2096
2023-08-09 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,257,343 83,672 1.36 631,414 11.17 0.2012
2023-05-12 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,173,671 180,186 3.01 567,974 104,499.26 0.1913
2023-02-09 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 5,993,485 -509,706 -7.84 544 -99.89 0.1606
2022-11-10 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,503,191 465,677 7.71 494,313 -3.14 0.1898
2022-08-12 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,037,514 1,680,152 38.56 510,352 33.47 0.1831
2022-05-13 2022-03-31 13F NOVARTIS ADR 66987V109 4,357,362 487,226 12.59 382,359 12.95 0.1178
2022-02-09 2021-12-31 13F NOVARTIS ADR 66987V109 3,870,136 1,003,235 34.99 338,521 44.39 0.1024
2021-11-12 2021-09-30 13F NOVARTIS ADR 66987V109 2,866,901 40,495 1.43 234,455 -9.08 0.0755
2021-08-12 2021-06-30 13F NOVARTIS ADR 66987V109 2,826,406 46,445 1.67 257,881 8.52 0.0816
2021-05-14 2021-03-31 13F NOVARTIS ADR 66987V109 2,779,961 -16,350 -0.58 237,631 -10.01 0.0786
2021-03-08 2020-12-31 13F/A-2 NOVARTIS ADR 66987V109 2,796,311 64,713 2.37 264,056 11.16 0.0954
2021-02-11 2020-12-31 13F NOVARTIS ADR 66987V109 2,796,311 64,713 264,056 95,362.9919
2020-11-12 2020-09-30 13F NOVARTIS ADR 66987V109 2,731,598 340,874 14.26 237,540 13.76 0.1007
2020-08-13 2020-06-30 13F NOVARTIS ADR 66987V109 2,390,724 87,638 3.81 208,806 9.96 0.0918
2020-05-14 2020-03-31 13F NOVARTIS A G ADR 66987V109 2,303,086 121,933 5.59 189,889 -8.06 0.0989
2020-02-14 2019-12-31 13F NOVARTIS A G ADR 66987V109 2,181,153 5,494 0.25 206,533 9.24 0.0753
2019-11-12 2019-09-30 13F NOVARTIS A G ADR 66987V109 2,175,659 8,437 0.39 189,065 -4.46 0.0735
2019-08-13 2019-06-30 13F NOVARTIS A G ADR 66987V109 2,167,222 -112,128 -4.92 197,889 -9.70 0.0768
2019-08-12 2019-03-31 13F/A-2 NOVARTIS A G ADR 66987V109 2,279,350 -10,077 -0.44 219,137 11.55 0.0873
2019-05-10 2019-03-31 13F NOVARTIS A G ADR 66987V109 2,279,350 -10,077 219,137
2019-02-26 2018-12-31 13F/A-1 NOVARTIS A G ADR 66987V109 2,289,427 15,883 0.70 196,456 0.29 0.0890
2019-02-13 2018-12-31 13F NOVARTIS A G ADR 66987V109 2,289,427 15,883 196,456
2018-11-13 2018-09-30 13F NOVARTIS A G ADR 66987V109 2,273,544 -29,002 -1.26 195,889 12.62 0.0746
2018-08-10 2018-06-30 13F NOVARTIS A G ADR 66987V109 2,302,546 210,398 10.06 173,934 2.83 0.0693
2018-05-11 2018-03-31 13F NOVARTIS A G ADR 66987V109 2,092,148 218,001 11.63 169,150 7.50 0.0705
2018-02-12 2017-12-31 13F NOVARTIS A G ADR 66987V109 1,874,147 165,980 9.72 157,353 7.30 0.0652
2017-11-13 2017-09-30 13F NOVARTIS A G ADR 66987V109 1,708,167 -132,022 -7.17 146,646 -4.53 0.0641
2017-08-11 2017-06-30 13F NOVARTIS A G ADR 66987V109 1,840,189 257,123 16.24 153,601 30.64 0.0709
2017-05-12 2017-03-31 13F NOVARTIS A G ADR 66987V109 1,583,066 375,426 31.09 117,574 33.66 0.0562
2017-02-09 2016-12-31 13F NOVARTIS A G ADR 66987V109 1,207,640 -10,685 -0.88 87,964 -8.56 0.0439
2016-11-10 2016-09-30 13F NOVARTIS A G ADR 66987V109 1,218,325 5,220 0.43 96,199 -3.89 0.0520
2016-08-09 2016-06-30 13F NOVARTIS A G ADR 66987V109 1,213,105 6,130 0.51 100,093 14.48 0.0576
2016-05-13 2016-03-31 13F NOVARTIS A G ADR 66987V109 1,206,975 29,203 2.48 87,433 -13.72 0.0523
2016-02-10 2015-12-31 13F NOVARTIS A G ADR 66987V109 1,177,772 25,162 2.18 101,336 -4.35 0.0632
2015-11-13 2015-09-30 13F NOVARTIS A G ADR 66987V109 1,152,610 -2,314 -0.20 105,948 -6.72 0.0695
2015-08-14 2015-06-30 13F NOVARTIS A G ADR 66987V109 1,154,924 -532,875 -31.57 113,575 -31.76 0.0695
2015-05-14 2015-03-31 13F NOVARTIS A G ADR 66987V109 1,687,799 -361,727 -17.65 166,434 -12.36 0.1051
2015-02-06 2014-12-31 13F NOVARTIS A G ADR 66987V109 2,049,526 -1,347 -0.07 189,909 -1.63 0.1247
2014-11-13 2014-09-30 13F NOVARTIS A G ADR 66987V109 2,050,873 -8,269 -0.40 193,049 3.56 0.1368
2014-08-08 2014-06-30 13F NOVARTIS A G ADR 66987V109 2,059,142 -18,500 -0.89 186,414 5.53 0.1296
2014-05-14 2014-03-31 13F NOVARTIS A G ADR 66987V109 2,077,642 -97,854 -4.50 176,641 1.02 0.1320
2014-02-12 2013-12-31 13F NOVARTIS A G ADR 66987V109 2,175,496 163,701 8.14 174,866 13.31 0.1363
2013-11-13 2013-09-30 13F NOVARTIS A G ADR 66987V109 2,011,795 1,700 0.08 154,325 8.58 0.1336
2013-08-15 2013-06-30 13F NOVARTIS A G ADR 66987V109 2,010,095 2,010,095 142,134 0.1338
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.